Wilhelmina E. van Riel
GlaxoSmithKline (Netherlands)(NL)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Cellular Mechanics and Interactions, Cellular transport and secretion, Lung Cancer Treatments and Mutations, Genetics, Aging, and Longevity in Model Organisms
Most-Cited Works
- → CFEOM1-Associated Kinesin KIF21A Is a Cortical Microtubule Growth Inhibitor(2013)197 cited
- → MAP7 family proteins regulate kinesin-1 recruitment and activation(2019)176 cited
- → Tumor Type-Dependent Function of the Par3 Polarity Protein in Skin Tumorigenesis(2012)115 cited
- → Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells(2012)109 cited
- → Kinesin-4 KIF21B is a potent microtubule pausing factor(2017)66 cited
- → Kinesin-4 KIF21B limits microtubule growth to allow rapid centrosome polarization in T cells(2020)52 cited
- → Structural basis for misregulation of kinesin KIF21A autoinhibition by CFEOM1 disease mutations(2016)35 cited
- → Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020(2022)20 cited
- → Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites(2020)13 cited
- → Abstract 5645: BAL0891: A novel dual TTK/PLK1 mitotic checkpoint inhibitor (MCI) that drives aberrant tumor cell division resulting in potent anti-cancer activity(2022)3 cited